Simplify back-to-school season meal planning with Avocados from Mexico
|
||
|
Author: trainitright
Balance Calories Initiative – Success is in the Numbers
Conference Board of Canada reports calories are down from non-alcoholic beverages consumed by Canadians across all ages and regions.
TORONTO, Aug. 21, 2018 /CNW/ - The Canadian beverage industry's Balance Calories Initiative is helping to reduce the calories consumed from beverages across all ages and regions according to The Conference Board of Canada newest report – Counting the Calories. The report looks deeper into consumption rates of non-alcoholic beverages based on Statistics Canada's latest Canadian Community Health Survey – Nutrition Survey data. A collaboration between StatsCan, Health Canada and provincial health ministries, the Canadian Community Health Survey is the largest Canadian government survey to assess what Canadians are eating and drinking.
As leaders in innovation in the beverage sector, CBA members are working to help reduce the number of calories that Canadians consume from non-alcoholic beverages by reducing sugars in recipes, introducing smaller portion sizes and providing more low and no-calorie beverage options.
Report highlights:
- According to data from the latest Canadian Community Health Survey, between 2004 and 2015, all provinces are following the general trend towards fewer calories/day from non-alcoholic beverages including regions where obesity rates have increased.
- Despite the fact that obesity rates continue to rise in Canada, overweight Canadians reduced their beverage calorie consumption by 45% and obese Canadians by 41% between 2004 and 2015.
- Calories from non-alcoholic beverages in diets of children (1-13yrs) have decreased by 47% (to 95 kcal/day) and for adolescent (14-18yrs) diets calories have decreased by 46% since 2004 (to 140 kcal/day)
- The contribution of non-alcoholic beverages to the average 2,000 kcal diet went from 7.4% of daily calories in 2004 down to 4.1% of daily calories in 2015.
- There has been a greater than 30% reduction in calories consumed by Canadians overall from non-alcoholic beverages due to changing tastes and product innovation in the beverage industry.
"This report helps to dispel persistent myths about over-consumption of non-alcoholic beverages by Canadians," said Jim Goetz, President of the CBA. "Children, obese/overweight persons and Canadians as a whole are seeing reductions in the calories they are consuming from beverages – our industry is doing our part to address the portion of calories we represent, but, it is clear a holistic approach to the diet of Canadians is needed to continue to support better health outcomes."
About the Balance Calories Initiative:
Balance Calories Initiative (BCI) -- a voluntary initiative by members of the Canadian Beverage Association -- was launched in 2015 with the goal of reducing calories consumed from non-alcoholic beverages per capita/per day by 20% by 2025. In just three years, the initiative is more than half-way (10.2%) to its goal of 20%.
The Canadian beverage industry has a successful track record of leading voluntary initiatives. They include: voluntarily restricting marketing to children; eliminating full-calorie soft drinks from schools; and implementing front-of-pack calorie labeling, an initiative known as Clear on Calories.
The Conference Board of Canada, an evidence-based, action-oriented research organization with a non-partisan perspective, has partnered with Canadian Beverage Association and its members to benchmark and verify progress of this program.
SOURCE Canadian Beverage Association
Canadian public engagement platform Carrot Rewards announces one trillion steps tracked by its nearly one million users
TORONTO, Aug. 21, 2018 /CNW/ - Carrot Rewards — the world's first public engagement platform that rewards users for making healthier lifestyle choices — is thrilled to announce that its almost one million registered app users across Ontario, British Columbia and Newfoundland have tracked a combined one trillion steps on the Carrot Rewards platform since its launch in June 2016. That's equivalent to 18,000 walking trips around the earth!
In turn, Carrot Rewards' fiercely loyal and highly engaged users have earned 1.5 billion free rewards points from their favourite loyalty programs including Aeroplan® Miles, SCENE® Points, Petro-Points, More Rewards® Points, Drop points and RBC Rewards points — perks that are equivalent to 600,000 free movie tickets and much more.
"We are thrilled to see the impact that Carrot is having in the lives of Canadians. Half of our users engage with us every single day to learn more about improving their health and wellness, and our users walk 20% more within their first six months on Carrot," said Andreas Souvaliotis, Founder and CEO of Carrot Rewards.
This announcement comes as Carrot Rewards prepares to make the free platform available across the rest of Canada on November 1, 2018. Currently the popular app has 12% penetration in downtown Toronto, 10% penetration in Newfoundland and Labrador and 8% penetration in Vancouver. The company also recently launched several new app features, completed a landmark campaign with Health Canada in light of heat warnings in British Columbia, and sent six lucky Carrot Rewards users on trips across Canada as part of its Step into Summer contest.
About Carrot Rewards
Powered by AI, Carrot Rewards harnesses the power of mobile technology, Canada's favourite loyalty rewards programs and behavioural science to educate and motivate users towards healthier choices for themselves, their families and the planet. Carrot Rewards users earn their choice of rewards — including Aeroplan® Miles, SCENE® Points, Petro-Points, More Rewards® Points, Drop points and RBC Rewards points — every time they meet daily step goals, group activity challenges or complete quizzes and calls-to-action about health and wellness. Carrot's partners including the Public Health Agency of Canada, Health Canada, SickKids, Toronto Public Health, BC Cancer and Heart and Stroke Foundation of Canada earn the power to influence consumer behaviour by educating an engaged and attentive audience.
Currently available in Ontario, British Columbia and Newfoundland, Carrot Rewards users have tracked one trillion steps and completed 25 million healthy lifestyle and micro-learning quizzes and surveys. In return, users have earned 1.5 billion rewards points.
For more information, please visit: www.carrotapp.com
Twitter & Instagram: @carrot_rewards
Facebook: /carrotrewards
Available for interviews:
Andreas Souvaliotis, Founder and CEO, Carrot Rewards
Lorne Solway, Chief Marketing and Strategy Officer, Carrot Rewards
SOURCE Carrot Rewards
|
||||||||
Dr. Liz Cruz is a gastroenterologist, an author, and (most importantly,) a parent of four children. She is the creator of wellness products designed to promote all-natural, holistic wellness. Cruz's products have received critical acclaim and are widely praised for effectively reducing the need for prescription medicine. Cruz is a Diplomat of the American Board of Internal Medicine and the American Board of Gastroenterology. She is a member of the American Gastroenterological Association and the American Society for Gastrointestinal Endoscopy.ProMIS Neurosciences Oligomer Selective Antibody Therapeutic for Alzheimer's Disease, PMN310, Shows Potential for Improved Safety Profile in Direct Comparison to Other Amyloid Beta-Directed Antibodies in Clinical Development
TSX: PMN; OTCQB: ARFXF
Lack of PMN310 binding to amyloid deposits in Alzheimer's brain tissue may eliminate dose-limiting brain swelling seen with BAN2401 and aducanumab
TORONTO, and CAMBRIDGE, MA, Aug. 21, 2018 /CNW/ - ProMIS Neurosciences, Inc. (TSX: PMN; OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics selectively targeting toxic oligomers implicated in the development of neurodegenerative diseases, today announced that its lead antibody candidate for Alzheimer's disease (AD), PMN310, showed no binding to amyloid beta (Aß) plaque in AD brain samples in stark contrast to BAN2401 and aducanumab which both displayed robust Aß plaque reactivity. These findings extend the results ProMIS announced in January 2018, showing greater selectivity of PMN310 for Aß oligomers compared to aducanumab. Binding of therapeutic antibodies to Aß deposits in brain tissue, in particular blood vessels, is believed to underlie the development of ARIA (amyloid-related imaging abnormalities; brain swelling and microhemorrhages) in treated AD patients.
Commenting on these results, ProMIS President and CEO, Elliot Goldstein, MD, stated: "PMN310 was designed to selectively target soluble toxic Aß oligomers, now widely believed to be a root cause of AD. By not targeting Aß plaque, especially in and around blood vessels in the brain, we anticipate PMN310 may not be associated with the dose-limiting brain swelling seen with plaque-binding antibody therapeutics like BAN2401 and aducanumab. Confirmation of such an improved safety profile in clinical trials would allow for administration of higher doses to AD patients, thereby potentially leading to greater therapeutic potency of PMN310."
The binding profile of PMN310 in human AD brain tissues was directly compared to that of BAN2401 and aducanumab in a preclinical study using the technique of immunohistochemistry (IHC). Results of the study showed binding of BAN2401 and aducanumab to Aß plaque throughout the brain and in association with blood vessels. Conversely, binding of PMN310 to Aß plaque was not observed in any region of the AD brain tissues.
BAN2401 (Esai/Biogen) and aducanumab (Biogen) appear to target both Aß plaque and soluble Aß oligomers. Recent clinical trials with both BAN2401 and aducanumab, reporting a dose-related response curve (i.e., higher doses enabling greater efficacy) support the targeting of Aß oligomers for the treatment of AD and at the same time indicate that treatment with antibodies also targeting Aß plaque is associated with dose-limiting brain swelling in a significant percentage of AD patients. We have shown in multiple preclinical studies that PMN310 has the advantage of selectively targeting toxic Aß oligomers, with no "off-target" binding to Aß plaque, potentially allowing for the safe administration of higher effective doses of PMN310 compared to BAN2401 or aducanumab.
According to Dr. Goldstein, "Although both BAN2401 and aducanumab have shown encouraging phase 2 clinical results, the greater selectivity and avoidance of plaque binding with PMN310 may confer significant advantages in the clinic supporting PMN310 as potential 'best in class' therapy."
IHC is the process of selectively imaging antigens (e.g. proteins) in cells of a tissue section by exploiting the principle of antibodies (such as PMN310, aducanumab, BAN2401) binding specifically to their antigen targets in biological tissues. In the study referred to above, IHC was used to assess binding of Aß-directed antibodies to Aßplaque in AD brain tissue.
About ProMIS Neurosciences
ProMIS Neurosciences, Inc. is a development stage biotechnology company focused on discovering and developing antibody therapeutics selectively targeting toxic oligomers implicated in the development and progression of neurodegenerative diseases, in particular Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS) and Parkinson's disease (PD). The Company's proprietary target discovery engine is based on the use of two complementary techniques. The Company applies its thermodynamic, computational discovery platform—ProMIS™ and Collective Coordinates — to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins. Using this unique precision medicine approach, the Company is developing novel antibody therapeutics for AD, ALS and PD. ProMIS is headquartered in Toronto, Ontario, with offices in Cambridge, Massachusetts. ProMIS is listed on the Toronto Stock Exchange under the symbol PMN, and on the OTCQB Venture Market under the symbol ARFXF.
For further information please consult the Company's website at: www.promisneurosciences.com
Follow us on Twitter
Like us on LinkedIn
The TSX has not reviewed and does not accept responsibility for the adequacy or accuracy of this release. This information release contains certain forward-looking information, including about the timing and completion of the Offering, the receipt of TSX approval and the expected use of proceeds from the Offering. Such information involves known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by statements herein, and therefore these statements should not be read as guarantees of future performance or results. All forward-looking statements are based on the Company's current beliefs as well as assumptions made by and information currently available to it as well as other factors. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Due to risks and uncertainties, including the risks and uncertainties identified by the Company in its public securities filings, actual events may differ materially from current expectations. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Delta 9 Signs Multi-Year Agreement for Lift & Co.'s Cannabis Retail Training Certification
/NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. WIRE SERVICES/
WINNIPEG and TORONTO, Aug 21, 2018 /CNW/ - DELTA 9 CANNABIS INC. (TSXV: NINE) ("Delta 9" or the "Company") and LIFT CO. LTD. ("Lift & Co.") today announce a partnership that will see Lift & Co. train Delta 9 retail store employees across Canada using Lift & Co.'s leading-edge Cannabis Retail Training Certification (the "Certification").
The Certification was created by Lift & Co. through an exclusive partnership with MADD Canada. The Certification combines Lift & Co.'s years of experience educating legal cannabis consumers and MADD Canada's recognized expertise in responsible consumption into a self-guided online curriculum delivered through Lift & Co.'s retail education platform, with in-class components administered by MADD Canada.
"We want our retail staff to be the most knowledgeable in Canada," said Delta 9 Vice President of Sales and Marketing Marshall Posner. "A lot of people will be coming to our stores in October and many will not have very much knowledge about cannabis, how to use it safely and responsibly, and what effects they can expect from the various strains and products we sell. Our priority as a company is to ensure that everyone who walks into one of our stores can easily get the knowledge they need to make an informed choice, and we think Lift & Co. has developed the best and most comprehensive training course available."
"We are thrilled to enter into a multi-year partnership with Delta 9, one of Canada's oldest producers, and provide our best-in-class training program," said Matei Olaru, CEO, Lift & Co. "Delta 9 is committed to superior customer service, and with our program we'll prepare them for October 17th and beyond."
The Certification is delivered through an online content platform tailored for retailers and includes topics such as: fundamental product information on cannabis and the various ways it can be consumed; how cannabis is grown, tested and packaged; public health and harm reduction measures; plant genetics; the effects of terpenes; and how to use Lift & Co.'s product information to better guide customers through their purchase.
Delta 9 CEO John Arbuthnot said the company reviewed several options for training, but could not find any program as detailed as that provided by Lift & Co.
"We are very impressed with how thoroughly Lift & Co. has covered the topic, but also with their ability to provide product data in a way that is easy to use and very responsive to the needs of our staff and our customers," Arbuthnot said. "As one of Canada's first producers of legal cannabis, we also feel it's important to lead the way in terms of product safety and social responsibility. The sections created with MADD Canada are vital for us in creating a retail network that promotes the responsible use of cannabis, particularly in this first year of full legalization."
Delta 9 said training will be complete before the first retail outlets open for recreational sales in Manitoba on October 17. For more information on the Lift & Co. Cannabis Retail Certification, click here.
About Delta 9 Cannabis Inc.
Delta 9's wholly-owned subsidiary, Delta 9 Bio-Tech Inc., is a licensed producer of medical marijuana pursuant to the ACMPR and operates an 80,000 square foot production facility in Winnipeg, Manitoba, Canada. The company is also licensed for the operation of cannabis retail stores in Manitoba, and owns 50 per cent of the Delta West facility in Alberta. Delta 9's shares trade on the TSX Venture Exchange under the symbol "NINE".
About Lift & Co.
Lift & Co. (lift.co) is a media and tech platform with a mission of empowering the cannabis industry to make better-informed decisions through superior information and data. For consumers, Lift & Co. is like a "trip advisor" for cannabis, enabling discovery of cannabis products, producers, and retailers through content and user reviews. Lift & Co. also hosts Canada's premier consumer events: the Lift & Co. Expos, which are the largest cannabis consumer tradeshows in North America; and the national Canadian Cannabis Awards. For businesses, Lift & Co.'s proprietary database of market trends powers competitive analytics, targeted marketing and innovative retail solutions. Learn more at lift.co.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Disclaimer for Forward-Looking Information
Certain statements in this release are forward-looking statements, which reflect the expectations of management regarding the Company's future business plans and other matters. Forward-looking statements consist of statements that are not purely historical, including any statements regarding beliefs, plans, expectations or intentions regarding the future. Forward looking statements in this news release include statements relating to: (i) Delta 9's expansion plans; (ii) Delta 9's production of cannabis; (iii) approvals for Delta 9's production facilities by Health Canada; (iv) demand for Delta 9's products; and (v) Delta 9's cost to produce its grow pods. Such statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the statements, including that Delta 9's currently contemplated expansion and development plans may cease or otherwise change, Delta 9's production of cannabis may be lower than expected, Delta 9 may not obtain the required approvals from Health Canada, demand for Delta 9's products may be lower than anticipated, Delta 9's cost to produce its grow pods may be higher than expected and all other risk factors set forth in the filing statement of Delta 9 dated October 25, 2017 which has been filed on SEDAR. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are urged to consider these factors carefully in evaluating the forward-looking statements contained in this news release and are cautioned not to place undue reliance on such forward-looking statements, which are qualified in their entirety by these cautionary statements. These forward-looking statements are made as of the date hereof and the Company disclaims any intent or obligation to update publicly any forward-looking statements, whether as a result of new information, future events or results or otherwise, except as required by applicable securities laws.
By Choosing To Understand And Embrace Change, We Can Control It To Our Advantage
Morristown, TN, August 20, 2018 ― We are all affected constantly by change—and whether it's positive or negative change, our first response is usually fear. We fret over what this change will mean for us, and set up all sorts of scenarios in our mind of its possible outcome. But the truly successful men and women in business have a good understanding of change and use it to their advantage. If we continually avoid change, we stay in a rut and lose control of our life because we will have lost our freedom.
Ralph Masengill's latest book, Conquer Change and Win, is the result of forty years of experience as a consultant, coach, advisor and public relations strategist, observing change and showing business leaders that embracing and understanding positive change is the guaranteed way to effective quality improvement and substantial profit enhancement. Out of this experience Ralph learned that successful people share certain traits: they are willing to take a calculated risk and endorse positive change, and they have learned how change affects their emotions and how to overcome this fear.
Masengill speaks from wisdom learned over his vast career, infused by an ethics-based value system of helping others and the community. While his own life has had its share of personal challenges, tragedy and triumph—his professional career has been defined by great success. In fact, Masengill Marketing Associates has been the recipient of over 850 national and regional advertising and marketing awards. In Conquer Change and Win, this best-selling author gives readers an easy-to-follow book, peppered with humor, that includes clear charts and graphs to illustrate important points.
Masengill's quote says it all: "Quality, like the flu, is catching. The more you are around it, the more you will see the advantages and want to be a part of the quality process. In other words, quality begets quality.”
Ralph Masengill is a graduate of the University of Tennessee and his postgraduate work includes the Dr. W. Edwards Deming course on quality and quality management. He and his wife Dianne live near the Great Smoky Mountains in East Tennessee, where he enjoys woodworking, oil painting, sailing and helping with his favorite charities in his spare time. They have four grown children, two dogs and a cat.
For more information on the author or his book, please visit http://masengill.com.
Conquer Change and Win
Available at all fine bookstores, the author's website, and Amazon.com and Kindle.
ISBN: 978-1515191872
Excerpts from 5-Star Reviews on Amazon.com:
"All information is right on target for those seeking info on how to succeed in life and business. If you only want to read one book on this subject, this is certainly a great choice.”
"… A fascinating look at how the relentless change we experience in our professional and personal lives affects us physically and emotionally. His down to earth explanations of coping strategies coupled with bits of humor make change easier to manage. Masengill reminds us that fear of change is normal and the anxiety, stress and anger that we experience cannot be controlled and should not be ignored. The magic happens when you learn to control your response to these feelings… This book will teach you how… I found applications from these chapters helpful in everyday life, for who among us could not be more persuasive socially or at home?”
"While this book's subject is change and change management, it could have easily been about success or winning in life. Ralph is able to mix expertise, fact and even a little humor (some at his own expense) not only to teach, but to also tell a story to the reader … A very easy, delightful read that I would recommend to anyone who is interested in improving their own life and/or their company's well-being.”
"A must read for anyone struggling with doing what is difficult but necessary in order to be successful. Don't let the title fool you. This book is a complete user's guide for accomplishing just about anything. A great read whether you want to accelerate change in the workplace or in your personal life.
"… [Author] certainly knows what he's writing about, because he has lived it--in daily life, work, health, and business. Ralph's trademark has always been: "Knowledge through humor"--and it still is. Every day in every way, he's a winner and has certainly conquered many changes to make his life great again when times were tough. And this book reflects how others can become conquerors, changers, and winners too!”
Lifestyle Changes: 4 Unique Ways to Improve Your Health and Wellness
In a world where people are growing increasingly unhealthy, it is important to keep your body in tip top shape more than ever before. By avoiding the need to frequently visit your doctor, you will save loads of money on expensive medical issues, and be less prone to be put on unnecessary medications. The following are four unique ways to improve your health and wellness.
Exercise Each Day
You probably already know that exercise is a critical part to maintaining a healthy lifestyle. What you may not know is that the best way to exercise is in short 15-minute sessions each day. When you start pushing for long exercise sessions, this can actually be damaging to your heart. Shorter, intense workouts have shown to do a lot more for maintaining health than when people exercise longer. Less rigorous exercise, such as a brisk walk, may be okay for 30-minutes, but this type of exercise is not so hard on your body.
Drink More Water
One thing too many people fail to do is drink enough pure waterthroughout their daily routine. Your kidneys actually need a good amount of water each day to properly filter waste products out of your body. So, by getting 64 to 128 ounces of water each day, you will be helping to keep your blood cleaner and your body far less toxic overall.
Deep Breathing
You have probably heard people say that you need to get your body to go alkaline. In fact, people eat and drink in more alkaline ways, but the easiest way to change the pH of your body more alkaline is to breathe deeply. As you breathe deeply, you will be releasing carbon dioxide and your body’s pH will increase as it moves from a lower acidic pH to a higher more alkaline pH instead. Furthermore, you will be able to get your body to go alkaline without tampering with the necessary highly acidic state of your stomach in the process.
Be Happy
As has been reported by the medical professionals running Skylonda Lodge, happiness is a primary key to a longer, healthier life. When you are negative all the time, you put your body through a tremendous amount of stress. This negative stress will wage war on your cells, and they will tend to shut down, not thrive. By practicing putting yourself in a good mood, you will significantly improve everything from your cell functionality to the way your immune system functions.
You only get one body in life, so you need to make sure it remains in a state of pristine health for as long as humanly possible. Otherwise, you will not enjoy life as you get older. There is no need to be riddled with aches, pains and an endless array of medical complications. So, now is the time to take command of your health and to ensure that you will be able to live a long, happy life where health is abundant.
High Tide Announces Conditional Approval by AGLC and Expects to Create over 400 Jobs
Calgary, AB, August 20, 2018 / CNW / − High Tide Ventures Inc. (“High Tide” or the “Company”) today announced that Alberta Gaming, Liquor & Cannabis (“AGLC”) has found Canna Cabana and its key representatives suitable for a one-year conditional approval in relation to its applications for retail cannabis store licenses. This is a major step towards becoming fully-licensed in the province of Alberta, with store inspections and licensing forming the final steps of the in-depth process. Those two steps are expected to occur closer to the legalization of recreational cannabis across Canada on October 17, 2018.
Receipt of conditional approval enables the Company to proceed confidently with the construction of all Canna Cabana stores for which it has development permits. “Since being established in 2009, this is truly one of the most important moments in our company’s history”, said Raj Grover, President & Chief Executive Officer of High Tide. “Receiving this conditional approval is a testament to the quality of the team that has been assembled to achieve the goal of becoming a major player in the downstream Canadian cannabis industry”, added Mr. Grover. As of today, High Tide is well on its way to being one of the largest recreational cannabis retailers in Alberta and is currently in possession of nine development permits for stores in the municipalities of Calgary, Edmonton, Fort Saskatchewan, Lethbridge, Morinville and Whitecourt.
Further to beginning construction on its stores, the Company will now also embark on conducting large job fairs in Calgary and Edmonton in September. Over 400 staff are expected to be hired, ranging in roles from sales associates to general managers. All staff working in the Company’s stores across Alberta will be required to hold a Qualified Cannabis Worker registration and complete the Sellsafe Cannabis Staff training program. SellSafe is a mandatory social responsibility training program designed to help retail cannabis staff understand what their responsibilities are to customers. The program also helps workers understand Alberta's cannabis laws and AGLC policies.
High Tide is positioned to be one of Canada’s largest retailers of cannabis products and lifestyle accessories. The Company expects to secure the maximum number of 37 retail cannabis outlets in Alberta, the maximum of eight expected locations in British Columbia, as well as a large number of leases for stores in Ontario as it prepares for the privatization of retail cannabis by April 1, 2019.
About High Tide Ventures Inc.
High Tide is a privately-held, Alberta-based, retail-focused cannabis corporation. It is among the most vertically-integrated companies in the Canadian cannabis market, with portfolio entities including RGR Canada, Smoker’s Corner, Famous Brandz, Canna Cabana and the majority of KushBar. High Tide’s strategy as a parent company is to extend and strengthen its retail-focused integrated value chain, while providing a complete customer experience and maximizing shareholder value.
Representing the core of High Tide’s business, RGR Canada is a high-quality and innovative designer, manufacturer and distributor of cannabis accessories. Founded in 2009 and approved by the Canadian Franchise Association, Smoker’s Corner is Canada’s largest counter-culture chain with 19 current locations. Famous Brandz is a dominant manufacturer of licensed lifestyle accessories, through partnerships with celebrities and entertainment companies like Snoop Dogg and Paramount Pictures, respectively, which are sold to wholesalers and retailers around the world. Upon the legalization of recreational cannabis across Canada on October 17, 2018, Canna Cabana is positioned to become a sizeable retail brand through a modern concept with a sophisticated yet playful customer experience, while KushBar is a retail concept that will also be focused on the valued Canadian cannabis consumer.
For more information about High Tide Ventures Inc., visit www.hightideventures.com
Forward-Looking Information
Certain statements in this news release are forward-looking information or forward-looking statements. Such information and statements, referred to herein as “forward-looking statements” are made as of the date of this news release or as of the date of the effective date of information described in this news release, as applicable. Forward-looking statements relate to future events or future performance and reflect current estimates, predictions, expectations or beliefs regarding future events. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance (generally, forward-looking statements can be identified by use of words such as “outlook”, “expects”, “intend”, “forecasts”, “anticipates”, “plans”, “projects”, “estimates”, “envisages, “assumes”, “needs”, “strategy”, “goals”, “objectives”, or variations thereof, or stating that certain actions, events or results “may”, “can”, “could”, “would”, “might”, or “will” be taken, occur or be achieved, or the negative of any of these terms or similar expressions, and other similar terminology) are not statements of historical fact and may be forward-looking statements.
Such forward-looking statements are based on assumptions that may prove to be incorrect, including but not limited to the ability of High Tide to execute on its business plan and that High Tide will receive one or multiple licenses from Alberta Gaming, Liquor & Cannabis, British Columbia’s Liquor Distribution Branch or the Saskatchewan Liquor and Gaming Authority permitting it to carry on its Canna Cabana and KushBar businesses. High Tide considers these assumptions to be reasonable in the circumstances, given the time periods for such outlook. However, there can be no assurance that any one or more of the government, industry, market, operational or financial targets as set out herein will be achieved. Inherent in the forward-looking statements are known and unknown risks, uncertainties and other factors that could cause actual results, performance or achievements, or industry results, to differ materially from any results, performance or achievements expressed or implied by such forward-looking statements.
The forward‐looking statements contained herein is current as of the date of this news release. Except as required by law, High Tide does not have any obligation to advise any person if it becomes aware of any inaccuracy in or omission from any forward-looking statement, nor does it intend, or assume any obligation, to update or revise these forward-looking statements to reflect new events or circumstances. Any and all forward-looking statements included in this news release are expressly qualified by this cautionary statement, and except as otherwise indicated, are made as of the date of this news release.
SOURCE High Tide Ventures Inc.
Urotronic Closes $20M Series B Round of Financing
The investment will support the company's mission to develop revolutionary technologies that transform the global urology market
Plymouth, Minnesota (August 20, 2018) - Plymouth based Urotronicannounced today it has raised $20 million in a strategic round led by HM (Hillhouse & Mayo Clinic) Ventures. Additional investments were made by CDBI Partners, OCXPROURO Limited andLegend Capital. The investments will support the growth of the innovative device called Optilume™which combines balloon dilation with the delivery of an anti-proliferative drug to inhibit recurrence of blockages in the urinary tract.
"We are excited about the accomplishments our team has made," said Urotronic CEO David Perry. “This investment is really a validation of our work to this point and Urotronic’s potential to truly transform the urology market through innovative treatments for BPH and urethral strictures."
In clinical trials performed both in Latin America and the United States, Optilume™ has performed as intended in both opening blockages and inhibiting the formation of scar tissue which can develop quickly after any medical intervention. The procedure can be performed in an outpatient setting, making it easier for physicians to learn and deliver to regions of the world where access to medical care is challenging.
That is an important consideration to investor Robert Luo, CEO of HM Capital, who notes international testing demonstrates the procedure can be implemented around the world. “We see the hope of minimally invasive technology that can really improve the outcomes as well as the experience of the patients,” he said.
The number of urological procedures is growing rapidly as global population’s age and men are more susceptible to urinary tract problems. BPH, or benign prostatic hyperplasia, impacts half of men by the age of 50. It becomes more prevalent with age as the prostate gland surrounds the male urethra, becomes enlarged and obstructs the flow of urine from the bladder. Likewise, urethral strictures impact millions of men each year. They are brought on byinfections, trauma and other urological procedures and can also block the pathway for urine.
In both cases, conventional treatments provide temporary relief but also include painful side effects. Some of the most invasive treatments include cutting, steaming or permanent implants which can lead to tissue damage and prolong healing time.
“This technology is very disruptive and the end beneficiary is going to be the patients,” said investor and company board member Doug Kohrs. “Urotronic has embarked on an approach to treating BPH and strictures that no one else has ever taken.”
The Series B financing will be used to expand the Urotronic team, manufacturing space and complete the required clinical studies toward commercial approval in international and domestic markets.
About Urotronic, Inc.
Urotronic, Inc., headquartered in Plymouth, Minnesota, is an early stage medical device company currently conducting clinical trials to support global commercialization of their products. The Optilume™ drug-coated balloon technology provides a low cost, minimally-invasive treatment option for men suffering from urinary track conditions like benign prostatic hyperplasia (BPH), urethral and ureteral strictures, and bladder neck contractures (BNC). The prevalence of BPH and lower urinary tract issues rises markedly with increased age. BPH affects 70% of men 60-69 years of age and 80% of those 70 years of age or older. The drug-coated balloon technology under development creates a paradigm change from the methods currently used by urologists to treat these conditions. For more information on Urotronic and our products, please visit us at http://urotronic.com/ or to schedule interviews with any of these stakeholders contact publicist Robb Leer 612.701.0608.
